Compare EQH & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQH | BAX |
|---|---|---|
| Founded | 1859 | 1931 |
| Country | United States | United States |
| Employees | 8000 | N/A |
| Industry | Specialty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 10.2B |
| IPO Year | N/A | 1994 |
| Metric | EQH | BAX |
|---|---|---|
| Price | $38.18 | $17.32 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 9 |
| Target Price | ★ $60.80 | $22.38 |
| AVG Volume (30 Days) | 2.8M | ★ 9.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.75% | 0.23% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $43.41 | $1.90 |
| Revenue Next Year | $7.61 | $2.09 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $37.51 | $17.40 |
| 52 Week High | $56.61 | $36.57 |
| Indicator | EQH | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 30.88 | 30.99 |
| Support Level | N/A | N/A |
| Resistance Level | $55.05 | $19.31 |
| Average True Range (ATR) | 1.69 | 0.76 |
| MACD | -0.28 | -0.41 |
| Stochastic Oscillator | 7.65 | 5.88 |
Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.